|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-4-1
|
|
pubmed:abstractText |
Thromboembolic events are serious complications in patients with inflammatory bowel disease (IBD). Resistance of factor V to degradation by activated protein C (APC) is a major cause for venous thrombosis and is found in approximately 30% of patients with thromboembolism. The aim of the present study was to assess the prevalence of APC resistance and clinical risk factors in patients with IBD.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
685-90
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10086652-Activated Protein C Resistance,
pubmed-meshheading:10086652-Adolescent,
pubmed-meshheading:10086652-Adult,
pubmed-meshheading:10086652-Aged,
pubmed-meshheading:10086652-Antithrombin III,
pubmed-meshheading:10086652-C-Reactive Protein,
pubmed-meshheading:10086652-Female,
pubmed-meshheading:10086652-Fibrinogen,
pubmed-meshheading:10086652-Humans,
pubmed-meshheading:10086652-Inflammatory Bowel Diseases,
pubmed-meshheading:10086652-Male,
pubmed-meshheading:10086652-Middle Aged,
pubmed-meshheading:10086652-Risk Factors,
pubmed-meshheading:10086652-Thromboembolism
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease.
|
|
pubmed:affiliation |
Department of Internal Medicine IV, Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article
|
